SCHEMBL30865069

SCHEMBL30865069

CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CS)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ KISS1R Q969F8 5/20 0.54
▸ OPRM1 P35372 3/20 0.51
▸ OPRD1 P41143 3/20 0.51
▸ OPRK1 P41145 1/20 0.51
▸ NPY1R P25929 1/20 0.50
▸ NPY2R P49146 1/20 0.50
▸ NPY4R P50391 1/20 0.50
▸ BACE1 P56817 1/20 0.49
▸ NTSR2 O95665 4/20 0.48
▸ NTSR1 P30989 4/20 0.48
▸ VIPR1 P32241 1/20 0.47
▸ SORT1 Q99523 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30184172 0.97 KISS1R (0.53) KISS1ROPRM1OPRD1OPRK1NPY1R
SCHEMBL31690551 0.95 KISS1R (0.56) KISS1RBACE1VIPR1
SCHEMBL29678306 0.95 KISS1R (0.56) KISS1RBACE1VIPR1
SCHEMBL30184408 0.94 BACE1 (0.56) KISS1ROPRM1OPRD1OPRK1NPY1R
SCHEMBL30865079 0.93 BACE1 (0.58) KISS1RNPY1RNPY2RNPY4RBACE1
SCHEMBL31690550 0.92 KISS1R (0.56) KISS1RBACE1VIPR1
SCHEMBL29627568 0.88 KISS1R (0.54) KISS1RBACE1VIPR1
SCHEMBL30712758 0.87 VIPR1 (0.50) KISS1RBACE1VIPR1
SCHEMBL31556395 0.86 ACE (0.53) KISS1RNPY1RNPY2RNPY4RBACE1
SCHEMBL31622480 0.86 VIPR1 (0.52) KISS1RBACE1VIPR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240041986-A1 METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF TYPE 1 DIABETES DR. MARY MORRIS & ASSOCIATES, LLC (US) 2024-02-08 — — US disclosed
Send feedback